Beam Therapeutics (BEAM) Shares Issued (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Shares Issued data on file, last reported at $12.7 million in Q1 2026.

• On a quarterly basis, Shares Issued rose 9.65% year-over-year to $12.7 million in Q1 2026; TTM through Mar 2026 was $12.7 million, a 9.65% increase from a year earlier, with the FY2025 full-year figure at $11.3 million, up 17.81% from the prior year.
• Shares Issued for Q1 2026 stood at $12.7 million, up from $11.3 million in the prior quarter.
• Over the last five years, Shares Issued for BEAM reached as high as $12.7 million in Q1 2026 and fell as low as $3.0 million in Q2 2022.
• Historically, Shares Issued has averaged $8.5 million across 5 years, with a median of $8.7 million in 2023.
• Across the five-year window, Shares Issued jumped 322.2% in 2022 and sank 46.15% in 2023, its largest moves.
• Year by year, Shares Issued stood at $7.5 million in 2022, then increased by 9.64% to $8.3 million in 2023, then climbed by 16.06% to $9.6 million in 2024, then grew by 17.81% to $11.3 million in 2025, then gained by 12.65% to $12.7 million in 2026.
• Per Business Quant data, the three most recent Shares Issued figures were $12.7 million in Q1 2026, $11.3 million in Q4 2025, and $11.5 million in Q3 2025.